SEATTLE, Oct. 23, 2012 – The U.S. Food and Drug Administration (FDA) is investigating a multistate outbreak of fungal meningitis and joint infections. It appears the outbreak is due to the contamination of an injectable steroid medication called methylprednisolone acetate produced by the New England Compounding Center (NECC). Swedish has never carried the methylprednisolone acetate product produced by NECC.
Information from Swedish on Multistate Fungal Meningitis Outbreak among Patients who Received Contaminated Steroid Injections
SEATTLE, Oct. 10, 2012 - You can't put a cast on a broken rib, but the FDA just approved a new treatment that speeds recovery from months to weeks.
Swedish to Host World’s First Live-Instagrammed, Live-Tweeted Hearing Restoration Surgery as Part of Month-Long Educational Web Series on Hearing Loss
SEATTLE, Sept. 26, 2012 - Swedish Medical Center and Douglas Backous, M.D., medical director of the Center for Hearing and Skull Base Surgery at the Swedish Neuroscience Institute, will host the world’s first live-instagrammed and live-tweeted cochlear implant (hearing restoration) surgery on Tuesday, Oct. 2 at 7 a.m. Pacific Time (PT).
ISSAQUAH, WASH., Sept. 13, 2012 – On Wednesday, Sept. 26 from 6-7:30 p.m. at Swedish/Issaquah (751 NE Blakely Drive, Issaquah) a free community health education program will be given by two experts in esophageal conditions. The 90-minute class will examine causes of heartburn and gastroesophageal reflux disease (GERD), as well as offer practical steps for personal management and treatment.
Hundreds of Swedish-Affiliated Providers Recognized as Part of Seattle and Seattle Met Magazines' Annual Top Doctors Surveys
SEATTLE, Sept. 11, 2012 - As they do each year, Seattle magazine and Seattle Met magazines published the results of their annual Top Doctors surveys in their July and August 2012 issues, respectively. To recognize the more than 300 Swedish-affiliated providers who were nominated by their peers for each survey, here is information about both efforts.
SEATTLE, March 30, 2012 - Seattle NBC affiliate KING Television (Channel 5) aired a story during their 5 p.m. PT newscast tonight about a relatively new, FDA-approved medical device called LifeVest ®. The wearable defibrillator is a treatment option for sudden cardiac arrest that offers patients advanced protection and monitoring as well as improved quality of life.
LifeVest is the first wearable defibrillator. Unlike an implantable cardioverter defibrillator (ICD), the LifeVest is worn outside the body rather than implanted in the chest. This device continuously monitors the patient's heart with dry, non-adhesive sensing electrodes to detect life-threatening abnormal heart rhythms. If a life-threatening rhythm is detected, the device alerts the patient prior to delivering a treatment shock, and thus allows a conscious patient to delay the treatment shock. If the patient becomes unconscious, the device releases a Blue™ gel over the therapy electrodes and delivers an electrical shock to restore normal rhythm.